UBS Group »

Drugs Made In America Acquisitn Unt shares owned by UBS Group

Quarter-by-quarter ownership of Drugs Made In America Acquisitn Unt (DMAAU) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Drugs Made In America Acquisitn Unt

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In America Acquisitn Unt held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In America Acquisitn Unt by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $191k 18k 10.40
2025-06-30 $190k 18k 10.32
2025-03-31 $186k 18k 10.17

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Drugs Made In America Acquisitn Unt

Omni Event Management
Wolverine Asset Management
Rivernorth Capital Management
DLD Asset Management
Clear Street
Robinson Capital Management
Tuttle Tactical Management
UBS Group
Citadel Advisors

View all funds holding Drugs Made In America Acquisitn Unt